GLP-1 Coverage: Limited but Growing Week of June 17th Newsletter

Topic of the Month on ModernWeight: Benefits!

Head to the Social Hub to chat on the benefits of GLP-1 medications, including but not limited to weight loss.

AOMs in the News

Health Changes After Stopping Mounjaro and Zepbound

Link: Healthline Article

Patients stopping Mounjaro and Zepbound may experience weight regain and other metabolic changes. This highlights the importance of long-term strategies in obesity management to maintain the benefits achieved through these wonder drugs.

Employers Increasingly Covering GLP-1 Drugs

Link: BenefitsPro Article

A new survey finds that more employers are beginning to cover GLP-1 drugs for weight loss. This trend reflects growing recognition of the importance of supporting employees in managing their weight and improving overall health.

Revolutionizing Management of Type 2 Diabetes (T2D) and Obesity

Link: AJMC Article

Experts discuss how GLP-1 drugs have transformed the treatment landscape for type 2 diabetes and obesity. These wonder drugs offer unprecedented effectiveness in managing both conditions, marking a significant advancement in patient care.

Limited Affordable Care Act (ACA) Marketplace Coverage for GLP-1 Drugs

Link: PharmaNewsIntel Article

A recent report reveals that only 1% of ACA marketplace plans cover GLP-1 drugs for obesity. This limited coverage poses challenges for patients seeking these effective treatments for weight management.

PatchMD Releases Medical Weight Loss Patch

Link: Yahoo Finance Article

PatchMD has launched a new medical weight loss patch that delivers GLP-1 agonists through the skin. Additionally, PatchMD is posting a series of helpful resources, such as "GLP-1 Agonists Explained," to support patients in understanding and managing their treatments.

Expert Tweet of the Week

From @JAMA_current

"JAMA Medical News in Brief: Roughly 12% of US Adults Have Used a GLP-1 Drug Even If Unaffordable"

---

Our ModernWeight "Weekly Weight Management Insights" newsletter is designed to keep you informed and engaged with the latest in weight management and GLP-1 medications. Visit the Social Hub to join the conversation and connect with our community.

Want to receive this newsletter in your inbox weekly? Create a profile!